SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–InterVenn Biosciences, a life science company pioneering glycoproteomics to improve human health, today announced that senior management will present at the J.P. Morgan 41st annual Healthcare Conference on January 11, 2023 at 8:30 a.m. Pacific.
InterVenn’s management team will be available for one-on-one meetings with investors, analysts and other interested parties during the conference.
InterVenn Contact
Ramuné Carothers
Vice President, Corporate Communications
InterVenn Biosciences
media@venn.bio
Investor Contact
David Deuchler, CFA
Gilmartin Group
ir@venn.bio
2 Tower Place, 5th Floor,
South San Francisco, CA 94080
Bay Area Lab
